Substituted propane phosphinic acid esters

Details for Australian Patent Application No. 2006213663 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Choi-Sledeski, Yong Mi; Collis, Alan John; Poli, Gregory Bernard

Agent Watermark

Pub. Number AU-A-2006213663

PCT Pub. Number WO2006/086734

Priority 60/652,152 11.02.05 US

Filing date 10 February 2006

Wipo publication date 17 August 2006

International Classifications

C07F 9/655 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/66 (2006.01) - Phosphorus compounds

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

C07F 9/48 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086734 Priority application(s): WO2006/086734

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213664-Identification system and method for medication management

2006213662-Process for preparing maytansinoid antibody conjugates